Published in Toxicol In Vitro on December 15, 2010
The European Partnership for Alternative Approaches to Animal Testing (EPAA): promoting alternative methods in Europe and beyond. J Am Assoc Lab Anim Sci (2015) 0.79
Application of Gut Cell Models for Toxicological and Bioactivity Studies of Functional and Novel Foods. Foods (2012) 0.75
Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing. Toxicol In Vitro (2017) 0.75
Localization of the motor hand area to a knob on the precentral gyrus. A new landmark. Brain (1997) 7.24
Beta-COP is essential for biosynthetic membrane transport from the endoplasmic reticulum to the Golgi complex in vivo. Cell (1993) 4.24
CLIP-170 links endocytic vesicles to microtubules. Cell (1992) 3.97
A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis (1982) 3.10
A STUDY OF THE ACTION OF AMMONIUM CHLORID AND ORGANIC MERCURY COMPOUNDS. J Clin Invest (1926) 2.82
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev (2002) 2.68
Efficacy and safety of pramipexole in restless legs syndrome. Neurology (2006) 2.63
Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol (2013) 2.51
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33
Efficient transformation of Agrobacterium spp. by electroporation. Nucleic Acids Res (1989) 2.15
Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol (1996) 2.13
The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol Methods (1988) 2.04
Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature (1985) 1.98
Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes. Science (2000) 1.93
Written information given to patients and families by palliative care units: a national survey. Lancet (2000) 1.88
Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett (2004) 1.70
Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm (2002) 1.68
Connexin-related signaling in cell death: to live or let die? Cell Death Differ (2009) 1.67
Intrasomatic injection of radioactive precursors for studying transmitter synthesis in identified neurons of Aplysia californica. Proc Natl Acad Sci U S A (1973) 1.66
Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol (2000) 1.63
Counseling and testing TB patients for HIV: evaluation of three implementation models in Kinshasa, Congo. Int J Tuberc Lung Dis (2008) 1.60
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol (1999) 1.51
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
Brain tissue oxygen guided treatment supplementing ICP/CPP therapy after traumatic brain injury. J Neurol Neurosurg Psychiatry (2003) 1.49
Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology (1989) 1.45
Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol (1997) 1.43
Doppler ultrasonography of the ophthalmic and central retinal vessels. Arch Ophthalmol (1991) 1.43
Incorporation of ceramide 3B in dermatocosmetic emulsions: effect on the transepidermal water loss of sodium lauryl sulphate-damaged skin. J Eur Acad Dermatol Venereol (2000) 1.41
A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology (1999) 1.40
Repair of acetone- and sodium lauryl sulphate-damaged human skin barrier function using topically applied emulsions containing barrier lipids. J Eur Acad Dermatol Venereol (2002) 1.40
[Combined pancreas/kidney transplantation as standard procedure in therapy of type I diabetic patients in renal failure]. Chirurg (1996) 1.38
Augmentation cystoplasty in children without preoperative mechanical bowel preparation. J Pediatr Urol (2011) 1.37
The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs (2011) 1.35
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Yeast respond to hypotonic shock with a calcium pulse. J Biol Chem (1996) 1.32
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Physical activity and gestational weight gain: a meta-analysis of intervention trials. BJOG (2010) 1.29
HHV8 and skin cancers in immunosuppressed patients. Lancet (1996) 1.29
Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol (2004) 1.28
Identification of microsatellite sequences in Vitis riparia and their applicability for genotyping of different Vitis species. Genome (1999) 1.27
Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet (1989) 1.26
Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J Biol Chem (1999) 1.26
Hormonal correlates of reproductive seasonality in wild female hanuman langurs (Presbytis entellus). Am J Primatol (2000) 1.25
Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics. J Med Chem (2008) 1.22
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clin Pharmacol Ther (2011) 1.22
The role of K+ currents in frequency-dependent spike broadening in Aplysia R20 neurons: a dynamic-clamp analysis. J Neurosci (1996) 1.21
Molecular cloning and functional expression of beta1, 2-xylosyltransferase cDNA from Arabidopsis thaliana. FEBS Lett (2000) 1.21
Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer (2011) 1.19
Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib. Eur J Cancer (2006) 1.19
Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ (2008) 1.17
Structural elements common to mitosis and apoptosis. Tissue Cell (1999) 1.16
Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion (1995) 1.16
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut (1997) 1.16
Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res (2005) 1.15
Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol (2000) 1.15
Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.14
Detection of genotoxic effects of heavy metal contaminated soils with plant bioassays. Mutat Res (1998) 1.12
The impact of travel on cancer patients' experiences of treatment: a literature review. Eur J Cancer Care (Engl) (2000) 1.12
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol (1996) 1.11
Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol (1994) 1.11
Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol (1999) 1.10
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther (2001) 1.09
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase. J Med Chem (2000) 1.09
Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J Virol (2004) 1.09
Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol In Vitro (2013) 1.09
Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol (1996) 1.09
Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol (1996) 1.08
Loss of oestrus, concealed ovulation and paternity confusion in free-ranging Hanuman langurs. Proc Biol Sci (2001) 1.08
Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology (1997) 1.08
Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro (2001) 1.08
Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther (2000) 1.07
T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer (1995) 1.07
An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett (1993) 1.06
Molecular cloning and characterization of cDNA coding for beta1, 2N-acetylglucosaminyltransferase I (GlcNAc-TI) from Nicotiana tabacum. Glycobiology (1999) 1.06
The metabolism of leukotrienes in blood plasma studied by high-performance liquid chromatography. Biochim Biophys Acta (1985) 1.06
Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Arch Toxicol (2012) 1.05
Compact pnCCD-based X-ray camera with high spatial and energy resolution: a color X-ray camera. Anal Chem (2011) 1.05
Eating soya improves human memory. Psychopharmacology (Berl) (2001) 1.04
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol (2007) 1.04
Incidence of alcoholic chronic pancreatitis in Copenhagen. Scand J Gastroenterol (1982) 1.04
The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I. Nucleic Acids Res (2001) 1.04
DNA analyses support the hypothesis that infanticide is adaptive in langur monkeys. Proc Biol Sci (1999) 1.03
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol (1997) 1.03
The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol (1985) 1.03
Studies on the in vitro synthesis of beta-galactosidase: necessary components in the ribosomal wash. Arch Biochem Biophys (1974) 1.03
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors (1999) 1.02
A gene controlling sex in grapevines placed on a molecular marker-based genetic map. Genome (2000) 1.02
In vivo activation of CD4+ cells in AIDS. Science (1987) 1.02
Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix. J Biol Chem (2001) 1.00
Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. Eur J Pediatr (1983) 1.00
Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology (2003) 1.00
Generation of slow-reacting substance (leukotrienes) by endotoxin and lipid A from human polymorphonuclear granulocytes. Immunology (1984) 1.00
Molecular cloning of cDNA encoding N-acetylglucosaminyltransferase II from Arabidopsis thaliana. Glycoconj J (1999) 0.99
18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med (1999) 0.99
Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. Drug Metab Dispos (1997) 0.98